East/West CEO
Date: Location: Cost:
January 6 - 7, 2018 Four Seasons Hotel
757 Market Street
San Francisco, CA 94103
(415) 633-3000

Starting at $1950


Dress Code:
Business Attire


EAST/WEST CEO – January 6, 2018

Co-hosts: Michael Hayden, Tom Heyman, Sean McCarthy, Lisa McKerracher, John Mendlein, Paris Panayiotopoulos, David Pyott, John Reed, James Sapirstein, Paul Stoffels, Christoph Westphal

Time Agenda
8:00-9:00 am

Registration and Networking Breakfast

9:00-9:30 am

Welcoming Remarks
Stephen Cutler, CEO, ICON

9:30-10:00 am

Building a Biotech: Innovative Business Models
Punit Dhillon, President, OncoSec Medical; Lisa McKerracherFounder & CEO, BioAxone BioSciences;  Hamza Suria, President & CEO, AnaptysBio
Moderator: Jack ReichCEO, Renova Therapeutics 

10:00-10:30 am

Private Company Perspectives on Raising Capital and Partnering
Adam Bruce, CEO, TikoMed; Felix Karim, EVP, Business Development, Blade Therapeutics; Ivana Magovcevic-Liebisch, EVP, Chief Strategy & Corporate Development Officer, Axcella Health
Moderator: Donald NicholsonCEO, Nimbus Therapeutics

10:30-11:00 am

Funding Innovation While Balancing Risk: The VC Perspective
Marianne De Backer, VP, Venture Investments, Johnson & Johnson; Ken HaasPartner, Abingworth

11:00-11:30 am

Moderated Keynote
Gregory Simon
, President, Biden Cancer Initiative


11:30-12:00 pm

Digital Value in Therapeutics
Robert BratzlerCo-founder & CEO, BioTrak Therapeutics; Wasim MalikChief Digital Strategist, Roivant Sciences; Kenneth MunieManaging Director, Accenture 

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Ensuring Diversity and Inclusion 
Meeta Chatterjee, Head of Strategy, Transactions & Operations, Merck; James Sapirstein, CEO, Contravir Pharmaceuticals
Moderator: Julie Kampf, JBK Associates

1:30-2:00 pm

Global Markets: Biotech Access Across Borders
Luigi Costa, CEO, Nordic Nanovector ASA; Samantha Du, Chairman & CEO, Zai Laboratory; Carl Firth, CEO, Aslan Pharmaceuticals; Mark Rothera, CEO, Orchard Therapeutics
Moderator: Luc Dochez, CEO, Tusk Therapeutics

2:00-2:30 pm

Accessing Innovation in Drug Development
Charles Baum, CEO, Mirati Therapeutics; Rowan ChapmanHead of Innovation, California, Johnson & Johnson; Michael Hayden, CSO & President, Global R&D, Teva
Moderator: Stephen Cutler, CEO, ICON

2:30-2:50 pm

Large Biotech and Pharma Perspectives: Takeaways from Last Year
Gilmore O'Neil, SVP, Drug Innovation Units, Biogen; John Reed, Global Head of Pharma Research & Early Development, Roche
Moderator: Jeremy GoldbergAdvisor, TPG

2:50-3:20 pm

Networking Break

3:20-3:50 pm

New Trends in Oncology & Immunotherapy
Leena Das-Young, VP-Head of Late Phase Strategy & Development Group, Pfizer; Axel Hoos, SVP, Therapeutic Area Head, Oncology R&D, GlaxoSmithKline; Pascal TouchonGlobal Head Cell & Gene, Novartis Oncology; Debi Watson, VP, Janssen Business Development, Oncology, Johnson & Johnson
Moderator: Paris Panayiotopoulos, Board of Directors, Corbus Pharmaceuticals

3:50-4:20 pm

R&D Trends: What's Changed in the Pharma Pipeline?
Arthur Krieg
, CEO, Checkmate Pharmaceuticals; Malcolm Weir, CEO, Heptares

4:20-4:50 pm

Healthcare Market Outlook: Predictions for 2018
Sara Radcliffe, President & CEO, California Life Sciences Association
Moderator: Luc Dochez, CEO, Tusk Therapeutics

4:50-6:00 pm

Cocktails and Hors d'oeuvres

January 7, 2018

Co-hosts: Michael Hayden, Tom Heyman, Sean McCarthy, Lisa McKerracher, John Mendlein, Paris Panayiotopoulos, David Pyott, John Reed, James Sapirstein, Paul Stoffels, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:50 am

Welcoming Remarks
John Nicols, President & CEO, Codexis; Patrick Verheyen, Global Head, Janssen Business Development, Johnson & Johnson

8:50-9:20 am

Global Perspectives on Funding and Innovation
Gil Beyen
Chairman & CEO, ErytechTom Heyman, President, JJDC, Johnson & Johnson Innovation; Ken Horne, CEO, Symic Bio; Jonathan Isaacsohn,CEO, CinRx Pharmaceuticals


9:20-9:50 am

State of the Healthcare Industry: Building a Sustainable Future
Sean McCarthy, CEO, CytomX; Bill Newell, CEO, Sutro Biopharma; Daniel Paterson, COO, Verastem
Moderator: Philippe Lopes-Fernandes, SVP, Global Head of Licensing, BD & Alliance Management, EMD Serono

9:50-10:20 am

Moderated Keynote
David Pyott
, former Chairman & CEO, Allergan
Moderator: Christoph Westphal, Co-Founder & Partner, Longwood Fund

10:20-10:50 am

Networking Break

10:50-11:20 am

Evolving Biopharma Boards
William Heiden, President & CEO, AMAG Pharmaceuticals; Catherine Sohn, Chairman, BioEclipse Therapeutics

11:10-11:40 am

CFO Disrupters in Biotech

11:20-11:50 am

Mid-Cap Biotech: Challenges and Opportunities
Alan Ezekowitz, CEO, Abide Therapeutics; Denise McGinn,VP, Janssen Business Development, Cardiovascular Metabolism/Japan, Johnson & Johnson; Joe Payne, President & CEO, Arcturus Therapeutics
Moderator: Robert Forrester, CEO, Verastem

11:50-12:20 pm

Biotech Partnering: Strategies for Success
Dan O’Connor, CEO, OncoSec Medical; John Oyler, Founder & CEO, BeiGene 
Moderator: Jonathan Kfoury, Managing Partner, L.E.K. Consulting

12:20-1:20 pm

Networking Lunch

1:20-1:50 pm

Communication Perspectives: View Towards 2018
Seema Kumar
, VP, Innovation, Global Health and Science Policy Communication, Johnson & Johnson

1:50-2:20 pm

Venture Philanthropy and Entrepreneurship: Advancing Medical Innovation
Charlotte Hubbert
, Partner, Gates Foundation Venture CapitalJohn Mendlein, CEO & Director, aTyr Pharma

2:20-2:50 pm

Small-Cap and Private Biotech: Leveraging Potential
Julie Eastland, CFO & CBO, Cascadian Therapeutics;
Moderator: Edward Kaye, CEO, Stoke Therapeutics

2:50-3:20 pm

Networking Break

3:20-3:50 pm

Trends in Private Financing: Will the Capital Continue?

3:50-4:20 pm

Moderated Keynote
Paul Stoffels
, EVP & CSO, Johnson & Johnson
Moderator: John Nicols, President & CEO, Codexis

4:20-4:30 pm

Presentation of Lifetime Achievement Award
Tom Heyman
, 2017 Honoree  

4:30-5:30 pm

Cocktails and Hors d'oeuvres

Executive Sponsors: (see all sponsors)